Dipeptidyl Peptidase 4
- Name
- Dipeptidyl Peptidase 4
- Accession Number
- DBCAT002809
- Description
Not Available
- Drugs
Drug Drug Description Carmegliptin Carmegliptin has been used in trials studying the treatment of Diabetes Mellitus Type 2. Evogliptin Evogliptin has been used in trials studying the treatment and screening of Osteoporosis, Renal Impairment, Type 2 Diabetes Mellitus, Diabetes Mellitis Type 2, and Diabetes Mellitus, Type 2. - Drugs & Drug Targets
Drug Target Type